| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/21/2004 | EP1438966A2 Use of depsipeptide and congeners thereof as immunosuppressants for treating an infectious disease, an autoimmune disease, allergic reactions or a hyperproliferative skin disease |
| 07/21/2004 | EP1438329A1 Biologically active peptides and their use for repairing injured nerves |
| 07/21/2004 | EP1292608B1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 07/21/2004 | CN1514881A Enzymatic coupling of L-phenylalanine methyl ester and N-benzyloxycarbonyl-L-aspartic acid in continuous or fed-batch process |
| 07/21/2004 | CN1513871A Method of preparing tyrosine-serine-leucine tripeptide |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | CA2286733C Reverse-turn mimetics and methods relating thereto |
| 07/15/2004 | WO2004058747A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | WO2004058188A2 Vaccine compositions and methods |
| 07/15/2004 | WO2004057976A1 Ace inhibitory peptides from plant materials |
| 07/15/2004 | WO2004047772A3 Catalytic antioxidants and methods of use |
| 07/15/2004 | WO2003099202A3 Beta-secretase inhibitors |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003066670A3 Dipeptides and tripeptides with anti-inflammatory activity |
| 07/15/2004 | US20040138493 Non-racemic hexafluoreleucine, and methods of making and using it |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138304 Prodrugs of excitatory amino acids |
| 07/15/2004 | US20040138141 Novel heteroaryl peptidomimetics as thrombin receptor antagonists |
| 07/15/2004 | US20040138139 Diaminodicarboxylic acid/peptide gemini surfactants; drug delivery |
| 07/15/2004 | US20040138104 Peptides |
| 07/15/2004 | US20040138096 Immunoregulator |
| 07/15/2004 | US20040137559 Process for producing N-formylamino acid and use thereof |
| 07/15/2004 | US20040137558 by using a culture of a microbe having an ability to produce a dipeptide from an amino acid ester and an amino acid |
| 07/15/2004 | US20040136907 Compounds with binding affinity for both alpha v beta 3 and somatostatin receptors; arginine, glycine, aspartic acid; improved overall affinity for tumors |
| 07/15/2004 | DE10300361A1 Bohrhaltige Peptidverbindung Bohrhaltige peptide compound |
| 07/15/2004 | CA2511356A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | CA2510173A1 Vaccine compositions and methods |
| 07/14/2004 | EP1437362A1 Macrocyclic peptides inhibiting the hepatitis C virus ns3 protease |
| 07/14/2004 | EP1436255A1 Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | EP1435989A1 Ptp1b inhibitors and ligands |
| 07/14/2004 | EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 07/14/2004 | CN1512999A 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157223C Dolastatin-15 derivatives in combination with taxanes |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762174 Beta-alethine with melphalan or cyclophosphamide; prevents clinical appearance of a neoplastic or pre-neoplastic condition; immunomodulation; enhancing cell growth, vitality, differentiation; antisenescence |
| 07/13/2004 | US6762167 Methods for treating a patient undergoing chemotherapy |
| 07/13/2004 | US6762166 Complementary peptides for the proline-glycine-proline sequence as antagonists of polymorphonuclear leukocyte chemoattractants; treating alkali-injuried eyes |
| 07/13/2004 | US6762041 Reacting transferase or transglutaminase (calcium independent/dependent) with protein (insulin, albumin, egg white lysozyme) to label carboxyamide nitrogen of glutamic acid residue |
| 07/13/2004 | US6761922 Sweetener compositions containing aspartyl dipeptide ester compounds |
| 07/13/2004 | CA2137748C Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants |
| 07/08/2004 | WO2004056849A2 Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria |
| 07/08/2004 | US20040133027 Novel intermediate for sweetener with high sweetness and process for producing the same |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132637 Administering phenylalanine-methionine-arginine-phenylalaninamide tetrapeptide; drug screening for analgesics |
| 07/07/2004 | EP1434792A2 Peptidyl ketones as inhibitors of dpiv |
| 07/07/2004 | EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1156492C Somatostatin peptides |
| 07/06/2004 | US6759510 Useful for rapid identification of biologically active compounds ;include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins |
| 07/06/2004 | US6759509 Branched peptide linkers |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/06/2004 | US6759404 Inhibiting gamma-secretase activity; treating diseases associated with beta-amyloid production, such as alzheimer's disease |
| 07/06/2004 | US6759388 Surfactants that mimic the glycocalyx |
| 07/06/2004 | US6759384 Factor Xa inhibitors |
| 07/01/2004 | WO2004055042A1 Biologically active peptide conjugates |
| 07/01/2004 | WO2004046170A3 Tubulysins, method for producing the same and tubulysin preparations |
| 07/01/2004 | WO2004041840A3 Peptide-bound chromogens used for determining enzymatic activities |
| 07/01/2004 | WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 07/01/2004 | WO2004018498A3 Minicell display and products therefrom |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | US20040127682 Anti-lymphocyte globulin imunotoxin fusion protein for use in prevention and treatment of graft-versus-host disease, leukemias, lymphomas and autoimmune disorders |
| 07/01/2004 | US20040127477 Heterocyclic glycyl beta-alanine derivatives |
| 07/01/2004 | US20040127419 Methods of using truncated glial cell line-derived neurotrophic factor |
| 07/01/2004 | US20040126847 Preparing transgenic coryneform bacterium capable of expressing industrially useful heterologous proteins such as transglutaminase; bioreactors |
| 06/30/2004 | EP1433781A1 Pyrrolidine carboxylic acid derivatives |
| 06/30/2004 | EP1433485A2 A uro-genital condition treatment system |
| 06/30/2004 | EP1432733A2 Gene regulatory peptides |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432432A2 A cancer treatment system |
| 06/30/2004 | EP1326851B1 Substituted dipeptides as growth hormone secretagogues |
| 06/30/2004 | EP1173413B1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 06/30/2004 | CN1509336A Process for producing peptide |
| 06/30/2004 | CN1155571C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 06/30/2004 | CN1155402C Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 06/29/2004 | US6756511 Treating alzheimer's disease by preventing formation of insoluble amyloid beta and arresting its production |
| 06/29/2004 | US6756354 Stabilization of drugs |
| 06/29/2004 | US6756216 Batch processing using nucleophilic compound |
| 06/29/2004 | CA2315230C Anti-cryptococcal peptides |
| 06/29/2004 | CA2084163C Endothelin antagonistic substance |
| 06/24/2004 | WO2004053093A2 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating |
| 06/24/2004 | WO2004052921A1 Cyanomethyl derivatives as cysteine protease inhibitors |
| 06/24/2004 | WO2004052844A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 06/24/2004 | WO2004052773A2 Peptide nanostructures, methods for their preparation and use |
| 06/24/2004 | WO2004052304A2 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/24/2004 | WO2003107004A3 Method for isolating an allosteric effector of a receptor |
| 06/24/2004 | WO2003106481A8 A process of producing ala-gln dipeptide |
| 06/24/2004 | WO2003092736A3 Peptide nucleic acid conjugates with transporter peptides |
| 06/24/2004 | WO2003057200A3 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| 06/24/2004 | US20040122062 such as 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo-[4,3-c]pyridin-5-yl)-1-(R)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide |
| 06/24/2004 | US20040121960 For therapy of Alzheimer's and prion disease |
| 06/24/2004 | US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 06/24/2004 | US20040121941 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 06/24/2004 | CA2508769A1 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/24/2004 | CA2506114A1 Cyanomethyl derivatives as cysteine protease inhibitors |